Rs. Wu et al., Comparative analysis of IFN-gamma B7.1 and antisense TGF-beta gene transfer on the tumorigenicity of a poorly immunogenic metastatic mammary carcinoma, CANCER IMMU, 50(5), 2001, pp. 229-240
Cancer progression is attributed in part to immune evasion strategies that
include lack of co-stimulation, down-regulation of cell surface MHC molecul
es, and secretion of immunosuppressive factors, such as transforming, growt
h factor-beta (TGF-beta). Gene therapy has been employed to counter these m
echanisms of immune evasion by transference of B7.1, IFN-gamma or antisense
TGF-beta genes into tumor cells, resulting in cell surface expression of B
7.1, upregulation of MHC class I and class II molecules, or elimination of
tumor-derived TGF-beta, respectively. Although each of these transgenes has
been shown to alter tumorigenicity in murine models, a direct comparison o
f their efficacy has not been performed. In this study, we have employed a
very aggressive, poorly immunogenic and highly metastatic mammary model, 4T
1, to compare the efficacy of B7.1, IFN-gamma and antisense TGF-beta gene t
ransfer in stimulating an anti-tumor response. We demonstrate that both IFN
-gamma and antisense TGF-beta gene expression significantly reduced the tum
origenicity of these cells compared to mock transduced cells, with IFN-gamm
a having a greater effect. In contrast, B7.1 gene transfer did not affect t
he tumorigenicity of 4T1 cells. The anti-tumor response directed against an
tisense TGF-beta -expressing 4T1 tumors was mediated by CD4(+) and CD8(+) T
cells. However, CD8(+) T cells, and not CD4(+) T cells, appeared to mediat
e the anti-tumor response against IFN-gamma -expressing tumors. Treatment o
f tumor-bearing animals with IFN-gamma or antisense TGF-beta gene-modified
tumor cell vaccines reduced the number of clonogenic metastases to the lung
s and liver compared to treatment with mock-transduced cells. Finally, in a
residual disease model in which the primary tumor was excised and mice wer
e vaccinated with irradiated tumor cells, treatment of mice with vaccinatio
ns consisting of 4T1 cells expressing; both antisense TGF-beta and IFN-gamm
a genes was the most effective in prolonging survival.